Sanaria Looks To Use Robot For Malaria Research

New York Times: A Goal to Combat Malaria With the Help of a Robot
“In its effort to develop a unique malaria vaccine, the American company Sanaria wants to build a robot that will do what now requires a line of trained humans with microscopes: dissecting half-frozen mosquitoes with tiny needles to extract their salivary glands. Inside the glands are malaria parasites, the key ingredient of Sanaria’s vaccine…” (5/5).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.